Introduction: In patients with diffuse large B-cell lymphoma (DLBCL) socioeconomic status (SES) is associated with outcome in several population-based studies. The aim of this study was to further investigate the existence of disparities in treatment and survival. Methods: A population-based cohort study was performed including 343 consecutive patients with DLBCL, diagnosed between 2005 and 2012, in the North-west of the Netherlands. SES was based on the socioeconomic position within the Netherlands by use of postal code and categorized as low, intermediate or high. With multivariable logistic regression and Cox proportional hazard models the association between SES and respectively treatment and overall survival (OS) was evaluated. Results...
IF 7.702International audienceThe survival of patients with diffuse large B-cell lymphoma has increa...
IF 7.702International audienceThe survival of patients with diffuse large B-cell lymphoma has increa...
IF 7.702International audienceThe survival of patients with diffuse large B-cell lymphoma has increa...
Introduction: In patients with diffuse large B-cell lymphoma (DLBCL) socioeconomic status (SES) is a...
Introduction: In patients with diffuse large B-cell lymphoma (DLBCL) socioeconomic status (SES) is a...
Introduction: In patients with diffuse large B-cell lymphoma (DLBCL) socioeconomic status (SES) is a...
The influence of socioeconomic status (SES) on access to standard chemotherapy and/or monoclonal ant...
The influence of socioeconomic status (SES) on access to standard chemotherapy and/or monoclonal ant...
The influence of socioeconomic status (SES) on access to standard chemotherapy and/or monoclonal ant...
The influence of socioeconomic status (SES) on access to standard chemotherapy and/or monoclonal ant...
Despite advances in treatment, including the introduction of rituximab, survival after diffuse large...
Despite advances in treatment, including the introduction of rituximab, survival after diffuse large...
IF 7.702International audienceThe survival of patients with diffuse large B-cell lymphoma has increa...
IF 7.702International audienceThe survival of patients with diffuse large B-cell lymphoma has increa...
IF 7.702International audienceThe survival of patients with diffuse large B-cell lymphoma has increa...
IF 7.702International audienceThe survival of patients with diffuse large B-cell lymphoma has increa...
IF 7.702International audienceThe survival of patients with diffuse large B-cell lymphoma has increa...
IF 7.702International audienceThe survival of patients with diffuse large B-cell lymphoma has increa...
Introduction: In patients with diffuse large B-cell lymphoma (DLBCL) socioeconomic status (SES) is a...
Introduction: In patients with diffuse large B-cell lymphoma (DLBCL) socioeconomic status (SES) is a...
Introduction: In patients with diffuse large B-cell lymphoma (DLBCL) socioeconomic status (SES) is a...
The influence of socioeconomic status (SES) on access to standard chemotherapy and/or monoclonal ant...
The influence of socioeconomic status (SES) on access to standard chemotherapy and/or monoclonal ant...
The influence of socioeconomic status (SES) on access to standard chemotherapy and/or monoclonal ant...
The influence of socioeconomic status (SES) on access to standard chemotherapy and/or monoclonal ant...
Despite advances in treatment, including the introduction of rituximab, survival after diffuse large...
Despite advances in treatment, including the introduction of rituximab, survival after diffuse large...
IF 7.702International audienceThe survival of patients with diffuse large B-cell lymphoma has increa...
IF 7.702International audienceThe survival of patients with diffuse large B-cell lymphoma has increa...
IF 7.702International audienceThe survival of patients with diffuse large B-cell lymphoma has increa...
IF 7.702International audienceThe survival of patients with diffuse large B-cell lymphoma has increa...
IF 7.702International audienceThe survival of patients with diffuse large B-cell lymphoma has increa...
IF 7.702International audienceThe survival of patients with diffuse large B-cell lymphoma has increa...